Patent ID: 11913043
Assignee: RESEARCH DEVELOPMENT FOUNDATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 10:
11. The cell-targeted construct of claim 10, wherein the cytotoxic drug is paclitaxel, docetaxel, etoposide, tenoposide, vincristine, vinblastine, colchicine, doxorubicin, daunorubicin, mithramycin, actinomycin, puromycin, epirubicin, cyclophosphamide, methotrexate, cytarabine, fluorouracil, cisplatin, streptozotocin, minomycin C, dactinomycin or actinomycin, bleomycin, mithramycin, anthramycin, duocarmycin, ifosfamide, mitoxantrone, daunomycin, carminomycin, animoterin, melphalan, esperamicin, lexitropsin, auristatin E, auristatin F, monomethyl auristatin E (MMAE), monomethyl auristatin F (MMAF), AEB, AEVB, AEFP, eleuthorobin, netropsin, maytansine, or DM1.